carvedilol has been researched along with Hypertension, Malignant in 1 studies
Hypertension, Malignant: A condition of markedly elevated BLOOD PRESSURE with DIASTOLIC PRESSURE usually greater than 120 mm Hg. Malignant hypertension is characterized by widespread vascular damage, PAPILLEDEMA, retinopathy, HYPERTENSIVE ENCEPHALOPATHY, and renal dysfunction.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Massing, JL | 1 |
| Baille, N | 1 |
| Raddad, M | 1 |
| Gangloff, C | 1 |
| Lecourtois, P | 1 |
1 other study available for carvedilol and Hypertension, Malignant
| Article | Year |
|---|---|
[Benefits of a beta-blocking agent (carvedilol) on bilateral atherosclerotic renal artery stenosis. A case report].
Topics: Adrenergic beta-Antagonists; Aged; Carbazoles; Carvedilol; Coronary Artery Disease; Humans; Hyperten | 2004 |